CHICAGO — Five years after treatment, patients with severe aortic stenosis had comparable rates of all-cause mortality or disabling stroke, whether they received transcatheter aortic valve replacement ...
NEW ORLEANS — January 29, 2026 — At the 2026 Society of Thoracic Surgeons (STS) Annual Meeting, investigators will present a late-breaking study focused on surgical aortic valve replacement (SAVR) ...
Please provide your email address to receive an email when new articles are posted on . At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement ...
Patients with heart failure who took dapagliflozin, a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, after undergoing transcatheter aortic valve replacement (TAVR) were significantly less likely ...
[Clinical Conditions > Interventional/Surgery]; May 21, 2013. In vivo, VERITAS: Live case TAVR just as safe as closed-door procedures [Clinical Conditions > Interventional/Surgery]; May 09, 2013.
Please provide your email address to receive an email when new articles are posted on . Single antiplatelet therapy was tied to lower 6-month mortality risk vs. dual antiplatelet therapy after ...
Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic valve stenosis. With proven safety and efficacy, TAVR has become a standard therapeutic alternative to surgical ...
High-risk surgical patients with severe aortic stenosis who underwent a transcatheter aortic valve replacement experienced higher one-year survival rates than patients who underwent traditional ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Aurora St. Luke’s Medical Center and its team of world ...
The Co-STAR trial tested the performance of colchicine in preventing new-onset arrhythmias and subclinical leaflet thrombosis after TAVR. The choice of periprocedural treatment with colchicine was ...
Some don’t believe Dr. Luay Sayed when he tells them about his patient, Paul Ivan, 100, of Algonac, who not only underwent a transcatheter aortic valve replacement (TAVR) procedure in January but by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results